| 中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
|---|---|---|---|---|
| —— | Boc5-tobramycin | 172950-21-9 | C43H77N5O19 | 968.106 |
| —— | di-tert-butyl (((1S,3R,4S,5S,6R)-4-(((2R,3R,4S,5S,6R)-6-(azidomethyl)-4-((tertbutoxycarbonyl)amino)-3,5-dihydroxytetrahydro-2H-pyran-2-yl)oxy)-6-(((2R,3R,5S,6R)-3-((tert-butoxycarbonyl)amino)-methyl)-5-hydroxytetrahydro-2H-pyran-2-yl)oxy)-5-hydroxycyclohexane-1,3-diyl)dicarbamate | 519171-28-9 | C43H76N8O18 | 993.119 |
| —— | penta-NH-Boc-6''-O-trisyl tobramycin | 220612-64-6 | C58H99N5O21S | 1234.51 |
| 尼拉霉素 | tobramycin | 32986-56-4 | C18H37N5O9 | 467.52 |
| 中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
|---|---|---|---|---|
| —— | 6''-deoxy-6''-guanidino(Boc)7tobramycin | 1391763-75-9 | C54H96N8O22 | 1209.4 |
| —— | N-[[(2R,3S,4S,5R,6R)-4-amino-6-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-3,5-dihydroxyoxan-2-yl]methyl]heptadecanamide | —— | C35H70N6O9 | 718.976 |
| —— | N-[[(2R,3S,4S,5R,6R)-4-amino-6-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-3,5-dihydroxyoxan-2-yl]methyl]tridecanamide | —— | C31H62N6O9 | 662.868 |
| —— | N-[[(2R,3S,4S,5R,6R)-4-amino-6-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-3,5-dihydroxyoxan-2-yl]methyl]pentadecanamide | —— | C33H66N6O9 | 690.922 |
The first class of solution and solid-state emitters (SSSE) capable of mediating gene transfection of different cell lines is reported. These amphiphiles can self-assemble in presence of DNA, forming luminescent lipoplexes that feature low toxicity.